Aug 03, 2018
Intrexon to Present at the Jefferies 2018 Global Industrials Conference
May 24, 2018
Oxitec Launches Field Trial in Brazil for Next Generation Addition to Friendly(TM) Mosquitoes Platform
May 14, 2018
Intrexon to Participate in the Bank of America Merrill Lynch 2018 Healthcare Conference
May 03, 2018
Intrexon to Announce First Quarter 2018 Financial Results on May 10th
Apr 06, 2018
Technical Perspectives on Biotech Stocks -- Intrexon, Iovance Biotherapeutics, Jaguar Health, and Jazz Pharma
Mar 29, 2018
ActoBio Therapeutics Greenlighted by FDA to Commence a Phase Ib/IIa Trial with AG019 for the Treatment of Early Onset Type 1 Diabetes
Feb 22, 2018
Intrexon to Announce Fourth Quarter and Full Year 2017 Financial Results on March 1st
Jan 19, 2018
Intrexon Announces Closing of Public Offering of Common Stock and Exercise of Option by Underwriters
Jan 17, 2018
Intrexon Prices Public Offering of Common Stock
Jan 16, 2018
Quotidian Technical Highlights on Selected Biotech Stocks -- Voyager Therapeutics, Cambrex, Emergent BioSolutions, and Intrexon
Jan 04, 2018
Intrexon to Present at the 36th Annual J.P. Morgan Healthcare Conference
Jan 02, 2018
Intrexon Corporation Annual CEO Letter
Nov 27, 2017
Intrexon Announces Key Management Appointments
Nov 10, 2017
Intrexon to Present at the Stifel 2017 Healthcare Conference
Nov 01, 2017
Intrexon to Announce Third Quarter 2017 Financial Results on November 9th
Oct 24, 2017
Technical Reports on Biotech Equities -- Teligent, VIVUS, Kadmon, and Intrexon
Oct 23, 2017
Intrexon and Arch Pharmalabs Collaborate on Fermentative Production of an API to Replace Existing Process Sourced from Animals
Oct 19, 2017
Intrexon CEO to Participate in World Food Prize Leadership Panel on Global Hunger
Sep 19, 2017
Stock Performance Review on Biotech Industry -- Intrexon, Ampio Pharma, AmpliPhi Biosciences, and CorMedix
Aug 02, 2017
Intrexon to Announce Second Quarter and First Half 2017 Financial Results on August 9th